CPHA Canvax

"Throughout COVID-19, the FDA has been among many government agencies charged with communicating lifesaving information. Commissioner Dr. Robert Califf talks with Dr. Josh Sharfstein about how the politicization of the pandemic raised the stakes for the FDA and how the agency is learning to adapt in an age of rampant misinformation. They also discuss the FDA’s consideration of bivalent vaccines for authorization and what’s next for the pandemic response." - FDA Commissioner Dr. Robert Califf on Bivalent COVID-19 Vaccines, Combating Misinformation, and Building Trust

Rating See Comments Ratings

Category:

Vaccination Decision Making,Vaccine Hesitancy,Misconceptions,Monitoring and Surveillance,Outbreaks and Pandemics,COVID-19 Vaccination Decision Making
Vaccine Hesitancy
Misconceptions
Monitoring and Surveillance
Outbreaks and Pandemics
COVID-19

0 Comments

Using the comment box below, provide your feedback for this resource. Tell the immunization community how you used the resource, what worked, what didn't and the changes you made. The feedback provided will help inform the immunization community and improve upon the resource made available on CANVax.

All comments are anonymous. Submitted comments will be reviewed for approval by the CANVax team to ensure it meets content submission guidelines. Please note that although CANVax aims to approve comments in a timely manner, volume may result in delays.